Meribank Biotech Co (4724.TWO) Stock Price

Meribank Biotech Co Price

CLOSED
9.26TWD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 19.6% per year over the past 6 years to 471.76 M TWD. Meribank Biotech Co's net margin stands at -17.3%, up from -60.8% several years earlier. The stock trades about 12% above its 52-week low.

Meribank Biotech Co stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Meribank Biotech Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Meribank Biotech Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Meribank Biotech Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Meribank Biotech Co Stock Price History
DateMeribank Biotech Co Price
8/24/20269.26 TWD
8/21/20269.26 TWD
8/20/20268.80 TWD
8/19/20268.30 TWD
8/18/20268.62 TWD
8/17/20268.80 TWD
8/14/20268.55 TWD
8/13/20268.95 TWD
8/12/20268.89 TWD
8/11/20268.94 TWD
8/10/20268.80 TWD
8/7/20268.94 TWD
8/6/20269.09 TWD
8/5/20269.09 TWD
8/4/20269.35 TWD
8/3/20269.19 TWD
7/31/20269.02 TWD
7/30/20269.00 TWD
7/29/20269.09 TWD
7/28/20269.09 TWD
7/27/20269.40 TWD
7/24/20269.72 TWD
7/23/20269.71 TWD
7/22/20269.72 TWD
7/21/20269.56 TWD
7/20/20269.80 TWD
7/17/20269.78 TWD
7/16/202610.15 TWD
7/15/20269.98 TWD
7/14/20269.98 TWD
7/13/20269.89 TWD
7/10/202610.05 TWD
7/9/202610.05 TWD
7/8/20269.90 TWD
7/7/202610.10 TWD
7/6/202610.25 TWD
7/3/202610.15 TWD
7/2/202610.15 TWD
7/1/202610.15 TWD
6/30/202610.10 TWD
6/29/202610.15 TWD
6/26/202610.25 TWD
6/25/202610.10 TWD
6/24/202610.70 TWD
6/23/20269.95 TWD
6/22/20269.48 TWD
6/18/20269.49 TWD
6/17/20269.10 TWD
6/16/20269.90 TWD
6/15/20269.14 TWD
6/12/202610.00 TWD
6/11/202610.65 TWD
6/10/202611.05 TWD
6/9/202611.45 TWD
6/8/202611.45 TWD
6/5/202611.40 TWD
6/4/202611.70 TWD
6/3/202611.80 TWD
6/2/202612.10 TWD
6/1/202612.05 TWD
5/29/202612.25 TWD
5/28/202612.45 TWD
5/27/202612.50 TWD
5/26/202613.45 TWD
5/25/202614.05 TWD
5/22/202613.50 TWD
5/21/202612.15 TWD
5/20/202612.35 TWD
5/19/202612.35 TWD
5/18/202612.45 TWD
5/15/202612.55 TWD
5/14/202612.60 TWD
5/13/202612.85 TWD
5/12/202613.05 TWD
5/11/202612.75 TWD
5/8/202613.10 TWD
5/7/202612.95 TWD
5/6/202612.85 TWD
5/5/202613.15 TWD
5/4/202613.15 TWD
4/30/202613.35 TWD
4/29/202614.00 TWD
4/28/202613.95 TWD
4/27/202613.95 TWD
4/24/202614.15 TWD
4/23/202614.15 TWD
4/22/202614.10 TWD
4/21/202614.35 TWD
4/20/202614.65 TWD
4/17/202612.90 TWD
4/16/202612.55 TWD
4/15/202613.05 TWD
4/14/202612.85 TWD
4/13/202612.75 TWD
4/10/202612.85 TWD
4/9/202612.80 TWD
4/8/202612.85 TWD
4/7/202613.30 TWD
4/2/202613.00 TWD
4/1/202613.45 TWD
3/31/202613.60 TWD
3/30/202614.15 TWD
3/27/202614.05 TWD
3/26/202614.00 TWD
3/25/202614.00 TWD
3/24/202613.65 TWD
3/23/202614.25 TWD
3/20/202614.30 TWD
3/19/202614.30 TWD
3/18/202614.85 TWD
3/17/202614.65 TWD
3/16/202614.65 TWD
3/13/202615.00 TWD
3/12/202615.40 TWD
3/11/202615.55 TWD
3/10/202615.45 TWD
3/9/202616.20 TWD
3/6/202616.20 TWD
3/5/202614.45 TWD
3/4/202614.00 TWD
3/3/202614.60 TWD
3/2/202615.00 TWD
2/26/202615.20 TWD
2/25/202615.05 TWD
2/24/202614.95 TWD
2/23/202615.05 TWD
2/11/202614.40 TWD
2/10/202614.80 TWD
2/9/202615.05 TWD
2/6/202614.90 TWD
2/5/202614.90 TWD
2/4/202615.05 TWD
2/3/202615.05 TWD
2/2/202615.05 TWD
1/30/202614.55 TWD
1/29/202615.35 TWD
1/28/202615.35 TWD
1/27/202614.80 TWD
1/26/202615.45 TWD
1/23/202615.45 TWD
1/22/202615.50 TWD
1/21/202615.40 TWD
1/20/202615.40 TWD
1/19/202615.40 TWD
1/16/202615.40 TWD
1/15/202615.40 TWD
1/14/202615.40 TWD
1/13/202615.50 TWD
1/12/202615.50 TWD
1/9/202615.60 TWD
1/8/202615.55 TWD
1/7/202615.65 TWD
1/6/202615.65 TWD
1/5/202615.20 TWD
1/2/202616.20 TWD
12/31/202516.35 TWD
12/30/202516.55 TWD
12/29/202516.70 TWD
12/26/202516.25 TWD
12/24/202516.95 TWD
12/23/202517.00 TWD
12/22/202516.15 TWD
12/19/202515.95 TWD
12/18/202516.00 TWD
12/17/202516.15 TWD
12/16/202516.30 TWD
12/15/202516.35 TWD
12/12/202516.40 TWD
12/11/202516.75 TWD
12/10/202516.65 TWD
12/9/202516.85 TWD
12/8/202517.35 TWD
12/5/202515.80 TWD
12/4/202515.75 TWD
12/3/202515.75 TWD
12/2/202515.85 TWD
12/1/202515.80 TWD
11/28/202515.75 TWD
11/27/202515.90 TWD
11/26/202516.00 TWD
11/25/202515.75 TWD
11/24/202516.05 TWD
11/21/202516.20 TWD
11/20/202516.45 TWD
11/19/202516.35 TWD
11/18/202516.50 TWD
11/17/202517.00 TWD
11/14/202516.95 TWD
11/13/202516.25 TWD
11/12/202517.15 TWD
11/11/202516.70 TWD
11/10/202517.20 TWD
11/7/202517.40 TWD
11/6/202517.40 TWD
11/5/202517.00 TWD
11/4/202517.45 TWD
11/3/202517.55 TWD
10/31/202518.05 TWD
10/30/202518.60 TWD
10/29/202518.90 TWD
10/28/202518.95 TWD
10/27/202519.05 TWD
10/23/202518.65 TWD
10/22/202518.95 TWD
10/21/202518.25 TWD
10/20/202519.10 TWD
10/17/202518.40 TWD
10/16/202518.45 TWD
10/15/202518.70 TWD
10/14/202518.35 TWD
10/13/202517.80 TWD
10/9/202518.70 TWD
10/8/202518.75 TWD
10/7/202519.40 TWD
10/3/202519.45 TWD
10/2/202520.10 TWD
10/1/202520.00 TWD
9/30/202520.10 TWD
9/26/202520.30 TWD
9/25/202521.05 TWD
9/24/202521.20 TWD
9/23/202520.95 TWD
9/22/202520.40 TWD
9/19/202520.35 TWD
9/18/202521.00 TWD
9/17/202519.90 TWD
9/16/202521.00 TWD
9/15/202520.30 TWD
9/12/202520.70 TWD
9/11/202521.45 TWD
9/10/202522.05 TWD
9/9/202522.15 TWD
9/8/202521.80 TWD
9/5/202519.45 TWD
9/4/202518.90 TWD
9/3/202519.90 TWD
9/2/202522.00 TWD
9/1/202520.25 TWD
8/29/202517.60 TWD
8/28/202517.40 TWD
8/27/202517.55 TWD
Access this data via the Eulerpool API
Get Free API Key

Meribank Biotech Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
160.95 M TWD
-57.41 M TWD
-59.90 M TWD
Jan 1, 2020
194.39 M TWD
-70.11 M TWD
-54.46 M TWD
Jan 1, 2021
163.08 M TWD
-98.54 M TWD
-99.19 M TWD
Jan 1, 2022
180.12 M TWD
-109.78 M TWD
-102.13 M TWD
Jan 1, 2023
234.34 M TWD
-123.15 M TWD
-125.35 M TWD
Jan 1, 2024
366.43 M TWD
-86.67 M TWD
-94.71 M TWD
Jan 1, 2025
471.76 M TWD
-68.38 M TWD
-81.47 M TWD

Meribank Biotech Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 8:34 AM
 
REVENUEM TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITM TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
SHARESM
2019202020212022202320242025
160.00194.00163.00180.00234.00366.00471.00
–21.25-15.9810.4330.0056.4128.69
58.1359.2855.2152.2258.9752.7375.80
93.00115.0090.0094.00138.00193.00357.00
-57.00-70.00-98.00-109.00-123.00-86.00-68.00
-35.63-36.08-60.12-60.56-52.56-23.50-14.44
-59.00-54.00-99.00-102.00-125.00-94.00-81.00
–-8.4783.333.0322.55-24.80-13.83
87.9887.9887.9862.7862.9187.9887.98
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Meribank Biotech Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Meribank Biotech Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Meribank Biotech Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Meribank Biotech Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Meribank Biotech Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Meribank Biotech Co stock margins

The Meribank Biotech Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Meribank Biotech Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Meribank Biotech Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
57.80 %
-35.67 %
-37.22 %
Jan 1, 2020
59.23 %
-36.07 %
-28.01 %
Jan 1, 2021
55.22 %
-60.43 %
-60.83 %
Jan 1, 2022
52.61 %
-60.95 %
-56.70 %
Jan 1, 2023
59.26 %
-52.55 %
-53.49 %
Jan 1, 2024
52.93 %
-23.65 %
-25.85 %
Jan 1, 2025
75.80 %
-14.49 %
-17.27 %

Meribank Biotech Co Stock Revenue, EBIT, Earnings per Share

The Meribank Biotech Co earnings per share therefore indicates how much revenue Meribank Biotech Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2020
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2021
0.00 TWD
0.00 TWD
0.00 TWD
Jan 1, 2022
2.87 TWD
-1.75 TWD
-1.63 TWD
Jan 1, 2023
3.72 TWD
-1.96 TWD
-1.99 TWD
Jan 1, 2024
4.17 TWD
-0.99 TWD
-1.08 TWD
Jan 1, 2025
5.36 TWD
-0.78 TWD
-0.93 TWD

Meribank Biotech Co business model & stock analysis

Meribank Biotech Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Meribank Biotech Co historical P/E ratio, EBIT multiple, and P/S ratio

Meribank Biotech Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Meribank Biotech Co shares outstanding

The number of shares of Meribank Biotech Co was 87.98 M in 2025. This indicates how many shares Meribank Biotech Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
95.98 M Stocks
Jan 1, 2020
95.98 M Stocks
Jan 1, 2021
95.98 M Stocks
Jan 1, 2022
62.78 M Stocks
Jan 1, 2023
62.91 M Stocks
Jan 1, 2024
87.98 M Stocks
Jan 1, 2025
87.98 M Stocks
Price targets and forecasts for Meribank Biotech Co are not yet available.

Meribank Biotech Co Executives and Management Board

9 members · avg. age 45

Management

ZL

Mr. Zixian Liu

Deputy General Manager

–
YC

Ms. Yuxia Chen

Head of Finance & Accounting, Corporate Governance Officer

–

Board of Directors

YH

Mr. Yogi Hsuan (45)

Chairman of the Board · since 2013

–
JC

Jianfang Cai

Vice Chairman of the Board, General Manager

–
BC

Botong Chen

Director

–
MX

Mingzhi Xuan

Director

–
JW

Jiaxiang Wang

Independent Director

–
HX

Huiyue Xu

Independent Director

–

Frequently asked questions about Meribank Biotech Co

Converted at the current exchange rate, the Meribank Biotech Co share trades at 0.25 EUR (9.26 TWD).

No history available for Meribank Biotech Co.

The revenue cannot currently be calculated for Meribank Biotech Co.

The profit cannot currently be calculated for Meribank Biotech Co.

The P/E ratio cannot be calculated for Meribank Biotech Co at the moment.

The P/S cannot be calculated for Meribank Biotech Co currently.

The Eulerpool Quality Score for Meribank Biotech Co is 3/10.

The ISIN of Meribank Biotech Co is TW0004724000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Meribank Biotech Co is 4724.TWO. The ticker symbol is used to trade Meribank Biotech Co shares on the stock exchange.

Meribank Biotech Co paid dividends every year for the past 0 years.

Meribank Biotech Co is assigned to the '—' sector.

The dividends of Meribank Biotech Co are distributed in TWD.

All fundamentals and in-depth analysis of Meribank Biotech Co

Our stock analysis for Meribank Biotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Meribank Biotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Meribank Biotech Co Stock
Meribank Biotech Co Revenue→
Meribank Biotech Co Stock
Meribank Biotech Co Net Income→
Meribank Biotech Co Stock
Meribank Biotech Co P/E→
Meribank Biotech Co Stock
Meribank Biotech Co P/S→
Meribank Biotech Co Stock
Meribank Biotech Co EBIT→
Meribank Biotech Co Stock
Meribank Biotech Co Dividend→
Meribank Biotech Co Stock
Meribank Biotech Co Directors Dealings→
Meribank Biotech Co Stock
Meribank Biotech Co Stocks→
Meribank Biotech Co Stock
Meribank Biotech Co Market capitalization→
Meribank Biotech Co Stock
Meribank Biotech Co Debt→
Meribank Biotech Co Stock
Meribank Biotech Co Liabilities→
Meribank Biotech Co Stock
Meribank Biotech Co Equity→
Meribank Biotech Co Stock
Meribank Biotech Co AAQS→
Meribank Biotech Co Stock
Meribank Biotech Co Employees→
Meribank Biotech Co Stock
Meribank Biotech Co ROE→
Meribank Biotech Co Stock
Meribank Biotech Co ROA→
Meribank Biotech Co Stock
Meribank Biotech Co ROCE→
Meribank Biotech Co Stock
Meribank Biotech Co News→
Meribank Biotech Co Stock
Meribank Biotech Co Analyst Price Targets→

— Stocks

MessabenMerdeka Gold Resources PT TbkMeta Critical MineralsMercury Trade LinksMetaedgeMercury LaboratoriesMetaguestaiMercuries F&B CoMetalero MiningMerchants TrustMetaLightMercer BancorpAll Stocks A–Z →